SCM Pharma will provide scale-up services to BTG for the commercial launch of Varisolve (polidocanol endovenous microfoam (PEM)), a treatment for the appearance and symptoms of varicose veins. SCM has worked with BTG since 2005 assisting with clinical studies, including clinical trial supply for the recent Phase III trial.   To date, SCM Pharma has supported BTG with process development, sterile manufacturing, packaging and distribution to trial sites in the U.S. SCM will now be named on the NDA...